Leaderboards/Bipolar Disorder and Treatment

Bipolar Disorder and Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Iain H. Campbell
Royal Edinburgh Hospital
2
Mustafa Deniz Tutkunkardaş
Istanbul University
3
Hao Sun
Nanjing Brain Hospital
4
Jordi Requena Osete
Oslo University Hospital
5
Jamilah Silver
Stony Brook University
6
Cheng-Hung Liao
National Taiwan University
7
Jonne Lintunen
University of Eastern Finland
8
Shiral S. Gangadin
University Medical Center Groningen
9
Luísa de Siqueira Rotenberg
Universidade de São Paulo
10
Cecilia Ilaria Belfiore
Unknown

Papers

1
The metabolic overdrive hypothesis: hyperglycolysis and glutaminolysis in bipolar mania
Molecular Psychiatry|2024
40 cit.
2
A pilot study of a ketogenic diet in bipolar disorder: clinical, metabolic and magnetic resonance spectroscopy findings
BJPsych Open|2025
26 cit.
3
Irritability across adolescence: Examining longitudinal trajectory, stability, and associations with psychopathology and functioning at age 18
Journal of Affective Disorders|2024
13 cit.
4
Publication in Journal of Affective Disorders (2024) [12 citations, W4391057405]
Journal of Affective Disorders|2024
12 cit.
5
Publication in Translational Psychiatry (2025) [10 citations, W4407682569]
Translational Psychiatry|2025
10 cit.
6
Publication in Journal of Psychiatric Research (2024) [8 citations, W4390921392]
Journal of Psychiatric Research|2024
8 cit.
7
Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: A Nationwide cohort study on relapse risk and treatment safety
Acta Psychiatrica Scandinavica|2024
8 cit.
8
Irritability: associations with real-time affect dynamics, social interactions, and daily substance use in older adolescents
European Child & Adolescent Psychiatry|2024
5 cit.
9
Development and Validation of a Multi-Informant Scale for Assessing Youth Tonic and Phasic Irritability
Research on Child and Adolescent Psychopathology|2025
4 cit.
10
Metacognitive Training for Subjects with Bipolar Disorder: A Randomized Controlled Trial
Psychotherapy and Psychosomatics|2025
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Sjors M. M. Lange
GGZ inGeest
2
Valentina Marino
University of Chieti-Pescara
3
Alyson Zwicker
Dalhousie University
4
Maralice Conacci‐Sorrell
Southwestern Medical Center
5
Martin Osugo
King's College London
6
Handan Özek Erkuran
Dr. Behçet Uz Çocuk Hastalıkları Hastanesi
7
Halil İbrahim Taş
Ordu University
8
Onur Hurşıtoğlu
Kahramanmaraş Sütçü İmam University
9
Sinem Yolcu
Bakırköy Psychiatric Hospital
10
Rıdvan ney
Unknown

Papers

1
Tryptophan fuels MYC-dependent liver tumorigenesis through indole 3-pyruvate synthesis
Nature Communications|2024
45 cit.
2
Validity and reliability of the Turkish version of the Glasgow Sleep Effort Scale
Sleep Medicine|2022
26 cit.
3
Treating negative symptoms of schizophrenia: current approaches and future perspectives
The British Journal of Psychiatry|2023
26 cit.
4
Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected Parents
American Journal of Psychiatry|2023
25 cit.
5
Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients
Progress in Neuro-Psychopharmacology and Biological Psychiatry|2022
17 cit.
6
Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviour
Nature Communications|2025
17 cit.
7
The AHR target gene scinderin activates the WNT pathway by facilitating the nuclear translocation of β-catenin
Journal of Cell Science|2022
13 cit.
8
ZNF692 organizes a hub specialized in 40S ribosomal subunit maturation enhancing translation in rapidly proliferating cells
Cell Reports|2023
12 cit.
9
Psychometric properties of the Turkish reduced morningness and eveningness questionnaire
Chronobiology International|2024
11 cit.
10
Psychometric properties of the Turkish version of the Anxiety and Preoccupation about Sleep Questionnaire in clinical and non-clinical samples
Sleep Science|2022
10 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Eduard Vieta
Hospital Clínic de Barcelona
2
Martin B. Keller
Brown University
3
Denny Meyer
Swinburne University of Technology
4
Robert M. Post
George Washington University
5
Ellen Leibenluft
National Institute of Mental Health
6
Stephen M. Strakowski
Indiana University School of Medicine
7
Jair C. Soares
The University of Texas Health Science Center at Houston
8
Joseph R. Calabrese
Case Western Reserve University
9
Michael Berk
The Royal Melbourne Hospital
10
Flávio Kapczinski
Universidade Federal do Rio Grande do Sul

Papers

1
A Rating Scale for Mania: Reliability, Validity and Sensitivity
The British Journal of Psychiatry|1978
8.7k cit.
2
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
Biological Psychiatry|2003
3.9k cit.
3
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Archives of General Psychiatry|2002
2.1k cit.
4
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
Bipolar Disorders|2018
1.8k cit.
5
The Longitudinal Interval Follow-up Evaluation
Archives of General Psychiatry|1987
1.7k cit.
6
A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II Disorder
Archives of General Psychiatry|2003
1.2k cit.
7
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
Bipolar Disorders|2012
1.2k cit.
8
A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
The Journal of Clinical Psychiatry|1999
1.1k cit.
9
A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial)
BMC Medicine|2017
1.1k cit.
10
Guidelines for Developing and Reporting Machine Learning Predictive Models in Biomedical Research: A Multidisciplinary View
Journal of Medical Internet Research|2016
1k cit.

Reagents for Bipolar Disorder and Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

GATA-4 (D3A3M) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 350 Conjugate)

#31948$458
View Evidence →
Cell Signaling TechnologyEvidence 67

DYKDDDDK Tag (D6W5B) Rabbit Monoclonal Antibody (Binds to same epitope as Sigma-Aldrich Anti-FLAG M2 antibody) (mFluor™ Red 780 Conjugate)

#71323$465
View Evidence →
Cell Signaling TechnologyEvidence 66

NLRP3 (D2P5E) Rabbit Monoclonal Antibody

#13158$161,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

Nanog (D73G4) Rabbit Monoclonal Antibody (Alexa Fluor® 594 Conjugate)

Cited in 5 papers
#8750$465
View Evidence →
Cell Signaling TechnologyEvidence 64

HPK1 (E1C3L) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 532 Conjugate)

#50840$458
View Evidence →
Cell Signaling TechnologyEvidence 64

PU.1 (F2D5A) Mouse Monoclonal Antibody (PE Conjugate)

#57800$465
View Evidence →